Worst performer of the week was CAML:Central Asia Metals, losing 11% after the shares returned from suspension as they dropped down to around the placing price. I think we may be stuck around these levels until the placing is out of the way, but the enhanced profits should make this company an even better investment for the future.
IQE:IQE had another bad week, but not as bad as it has been. My SIPP holding only dropped by 2% but is now losing £163, but my ISA holding dropped 7% compared to my original cost price, but is still up by £6,137 (314%).
Far more good news stories this week, with CWR:Ceres Power Holdings climbing 6% which makes them up 59% on purchase price. REDS:RedstoneConnect climbed 7% after news of another contract and rumours they will be bought out. Could I finally get my trading account working properly?
OPTI:Optibiotix climbed a wonderful 9% following the clearing of the overhang left by an ex-director selling 1.75 million shares. That's now back in profit in all accounts and making paper profit of £1,395.
MTFB:Motif Bio is rising steadily and climbed another 9% this week making it up by 15% overall. I'm now excited about the prospects for this one.
Share of the Week for the second week in a row was RED:RedT Energy, climbing another 12% and now only losing £25 (2%). Could this get back into profit next week? There's momentum building as news of more and more sales comes in.
That's better - another week like the last 2 would have seen the red line crossed, which is something I'd rather never happen again.
The ISA and share accounts look like this
| Weekly Change | |||
| Cash | £43.34 | +£0 | |
| Portfolio cost | £44,426.84 | +£0 | |
| Portfolio sell value (bid price - commission) | £48,430.71 | (+9%) | +£1,757.59 |
| Potential profits | £8,595.26 | +£510.31 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £585.38 | +£0 | |
| Yr 3 Average monthly cash profit | £290.66 | (7.9%) | -£41.52 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,297.85 | +£0 | |
| Average monthly cash profit | £323.76 | (8.7%) | -£2.91 |
| (Sold stocks profit + Dividends - Fees / Months) |
Sell value up almost as much as I lost last week and most of it was vanishing OPTI:Optibiotix losses which explains why profits are only up by £510 along with the loss of a bit more of my IQE:IQE profit.
Much better.
The SIPP looks like this after week 96
| Weekly Change | |||
| Cash | £54.80 | +£0 | |
| Portfolio cost | £25,218.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £27,192.71 | (7.8%) | +£689.22 |
| Potential profits | £3,326.64 | +£748.83 | |
| Yr 2 Dividends | £328.84 | +£0 | |
| Yr 2 Profit from sales | £6,575.33 | +£0 | |
| Yr 2 Average monthly cash profit | £672.47 | (32%) | -£15.64 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £430.65 | (20.5%) | -£4.53 |
| (Sold stocks profit + Dividends - Fees / Months) |
Profits soared thanks to OPTI:Optibiotix but there were some losses like IQE:IQE and TRX:Tissue Regenix to knock off some of the shine. I'm getting quite worried about TRX:Tissue Regenix now, as they are down by 43% and nothing seems to be turning around the relentless fall.
Just like the other graphs - going back in the right direction
The trading account looks like this after week 62
| Weekly Change | |||
| Cash | £79.63 | +£0 | |
| Portfolio cost | £486.05 | +£0 | |
| Portfolio sell value (bid price - commission) | £371.69 | (-23.5%) | +£30.58 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.52 | (-3.8%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
At last there seems to be the chance of a turnaround. If I can get this up to £420 then I'll have my £500 back and I can think about using this account as it was meant to be used.
Nearly there!
Loads happening next week with final results from CWR:Ceres Power on Wednesday. They still won't be making a profit, but a summary of all the exciting work going on should help the share price continue upwards. News that trials of their fuel cell in a boiler reduced energy costs by £400 and carbon emissions by 2 tonnes a year were very exciting. In a few years the demand for power as everyone plugs in their electric car for the night will be massive, and distributed power generation could be the answer. A fuel cell in every boiler would be huge.
SBTX:SkinBiotherapeutics posts final results on Thursday. These are not likely to be great and may cause a decline in the share price, but all it takes is one nugget of future prospects and maybe the recent rise will continue, especially if OPTI:Optibiotix is now demonstrating the potential with this science. The feel good factor could spread.
CAML:Central Asia Metals is likely to have another bad week, as the ex-dividend date is Friday and will trigger a 6.5p drop. Al I can hope is that the price increases by that much over the week as people buy into the dividend.
The JLP:Jubilee Platinum bulletin board is awash with gossip about a potential deal that they think will be announced during the week. I'm a little more dubious and will believe it when I see it. There's no doubt that the momentum is improving in this one, although it ended the week lower than it started, so perception may have got ahead of reality.
My main hope for the week is that RED:RedT Energy can climb the 2% required to take it into profit. I only wish I had kept the faith and bought more when they were at rock bottom, but I was starting to believe they were never going to sell a unit. Now I'm back thinking this one could be enormous.
I'm rather looking forward to next week...
No comments:
Post a Comment